RENTON HOLLINGS 4
4 · ANAPTYSBIO, INC · Filed Dec 3, 2024
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
RENTON HOLLINGS
Director
Transactions
- Exercise/Conversion
Common Stock
2024-11-29$6.93/sh+10,000$69,300→ 11,950 total - Sale
Common Stock
2024-11-29$25.00/sh−10,000$250,000→ 1,950 total - Exercise/Conversion
Common Stock
2024-11-29−10,000→ 20,925 totalExercise: $6.93Exp: 2025-07-05→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration.
- [F2]The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025.
- [F3]In addition to the remaining options to purchase 20,925 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 95,541 shares of common stock, which options vest according to their terms.